Medable is to combine its end-to-end software platform with Vault Health’s diagnostic, logistics and remote care services capabilities for decentralized trials.
The alliance between the two companies is based on the companies’ commitment to bringing clinical trials to patients through remote monitoring and highly tactile services.
This move will help make trials more broad and accessible and eventually bring new drugs to market quickly.
Under the partnership, the companies will deliver a unified experience for patients, trial sites and sponsors by integrating Medable’s software-as-a-service (SaaS) platform and Vault’s technology operational expertise.
Sponsors will be able to effortlessly provide home health care visits and Vault televisits, in-home testing and diagnostics, virtual site expertise and associated logistics, scheduling and condition monitoring through the applications of Medable for patients and sites.
CEO and co-founder of Medable, Dr. Michelle Longmire, said, “The future of clinical research is decentralized, whether in a traditional clinic, a virtual site, a local pharmacy or someone’s home.
“Our association with Vault Health allows us to make clinical trial participation much more convenient for patients, providing them with easy testing and diagnostic options, as well as expert remote care they can access from anywhere. anywhere.
Vault is said to offer the first home PCR test, authorized by the United States Food and Drug Administration, on the market and has provided more than ten million Covid-19 tests.
Medable’s SaaS platform has been used in more than 150 decentralized and hybrid trials in 60 countries.
Last March, Medable partnered with Seqster to combine real patient data streams into a decentralized trial platform.